The Community Guide

- gsearch

Search Results

Narrow Results:

2019 1
2016 1
2013 1
2009 1
2007 1

Centers for Disease Control and Prevention (U.S.) 1
National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Immunization Safety Office. 1

United States 1

Conference Publications 1
Handbooks 1

1 - 5 of 5 Results

Refine Results

Refine Results:

Community flu : software to estimate the impact of an influenza pandemic on a simulated community with and without interventions

CITE Title : Community flu : software to estimate the impact of an influenza pandemic on a simulated community with and without interventions Personal Author(s) : Atkins, Charisma Y.;Meltzer, Martin I.;Haber, Michael J.; Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : August 10, 2009 Pages in Document : 84 numbered pages URL : https://stacks.cdc.gov/view/cdc/49287 Atkins, Charisma Y. et al. (2009). Community flu : software to estimate the impact of an influenza pandemic on a simulated community with and without interventions. Atkins, Charisma Y. and Meltzer, Martin I. and Haber, Michael J. "Community flu : software to estimate the impact of an influenza pandemic on a simulated community with and without interventions" (2009) Atkins, Charisma Y. et al. "Community flu : software to estimate the impact of an influenza pandemic on a simulated community with and without interventions" , 2009 Export RIS Citation Information.

:

Atkins, Charisma Y. ;

Meltzer, Martin I.

August 10, 2009

:

CommunityFlu 1.0 User Manual, Current Edition: August 10, 2009CommunityFlu software was developed to help state and local health authorities plan for ...
Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries

CITE Title : Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries Personal Author(s) : Baker, Julia M.;Tate, Jacqueline E.;Leon, Juan;Haber, Michael J.;Lopman, Benjamin A.; Published Date : December 30 2019 Source : PLoS Med. 16(12) URL : https://stacks.cdc.gov/view/cdc/90805 Baker, Julia M. et al. (2019). Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries. 16(12). Baker, Julia M. et al. "Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries" 16, no. 12 (2019) Baker, Julia M. et al. "Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries" vol. 16, no. 12, 2019 Export RIS Citation Information.

:

Baker, Julia M. ;

Tate, Jacqueline E.

December 30 2019 | PLoS Med. 16(12)

:

BackgroundDespite the success of rotavirus vaccines over the last decade, rotavirus remains a leading cause of severe diarrheal disease among young ch...
Effectiveness of Interventions to Reduce Contact Rates during a Simulated Influenza Pandemic

CITE Title : Effectiveness of Interventions to Reduce Contact Rates during a Simulated Influenza Pandemic Personal Author(s) : Haber, Michael J.;Shay, Davis K.;Davis, Xiaohong M.;Patel, Rajan;Jin, Xiaoping;Weintraub, Eric;Orenstein, Evan;Thompson, William W.; Published Date : Apr 2007 Source : Emerg Infect Dis. 13(4):581-589. URL : https://stacks.cdc.gov/view/cdc/16452 Haber, Michael J. et al. (2007). Effectiveness of Interventions to Reduce Contact Rates during a Simulated Influenza Pandemic. 13(4). Haber, Michael J. et al. "Effectiveness of Interventions to Reduce Contact Rates during a Simulated Influenza Pandemic" 13, no. 4 (2007) Haber, Michael J. et al. "Effectiveness of Interventions to Reduce Contact Rates during a Simulated Influenza Pandemic" vol. 13, no. 4, 2007 Export RIS Citation Information.

:

Haber, Michael J. ;

Shay, Davis K.

Apr 2007 | Emerg Infect Dis. 13(4):581-589.

:

Measures to decrease contact between persons during an influenza pandemic have been included in pandemic response plans. We used stochastic simulation...
Monitoring of intussusception after rotavirus vaccines—United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2012

CITE Title : Monitoring of intussusception after rotavirus vaccines—United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2012 Personal Author(s) : Haber, Penina;Patel, Manish;Pan, Yi;Baggs, James;Haber, Michael J.;Museru, Oidda I.;Yue, Xin;Lewis, Paige;DeStefano, Frank;Parashar, Umesh D.; Corporate Authors(s) : National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Immunization Safety Office. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2013 June 19-20 : Atlanta, GA) Published Date : June 20, 2013 Series : ACIP meeting Rotavirus Vaccine URL : https://stacks.cdc.gov/view/cdc/76420 Haber, Penina et al. (2013). Monitoring of intussusception after rotavirus vaccines—United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2012. 201302(020103). Haber, Penina et al. "Monitoring of intussusception after rotavirus vaccines—United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2012" 201302, no. 020103 (2013) Haber, Penina et al. "Monitoring of intussusception after rotavirus vaccines—United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2012" vol. 201302, no. 020103, 2013 Export RIS Citation Information.

:

Haber, Penina ;

Patel, Manish

June 20, 2013 | ACIP meeting Rotavirus Vaccine

:

03-Rotavirus-Haber.pdf
The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings

CITE Title : The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings Personal Author(s) : Foppa, Ivo M.;Ferdinands, Jill M.;Chaves, Sandra S.;Haber, Michael J.;Reynolds, Sue B.;Flannery, Brendan;Fry, Alicia M.; Published Date : Dec 01 2016 Source : Int J Epidemiol. 45(6):2052-2059. URL : https://stacks.cdc.gov/view/cdc/41344 Foppa, Ivo M. et al. (2016). The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings. 45(6). Foppa, Ivo M. et al. "The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings" 45, no. 6 (2016) Foppa, Ivo M. et al. "The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings" vol. 45, no. 6, 2016 Export RIS Citation Information.

:

Foppa, Ivo M. ;

Ferdinands, Jill M.

Dec 01 2016 | Int J Epidemiol. 45(6):2052-2059.

:

BackgroundThe test-negative design (TND) to evaluate influenza vaccine effectiveness is based on patients seeking care for acute respiratory infection...